Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 21, 2012
The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income countryMehlika Toy, Fatih Oguz Onder, Ramazan Idilman, et al.Journal of Vascular and Interventional Radiology : JVIR|September 1, 2015
A Single-Center Retrospective Comparison of Doxorubicin-Loaded HepaSphere Transarterial Chemoembolization with Conventional Transarterial Chemoembolization for Patients with Unresectable Hepatocellular CarcinomaFahrettin Kucukay, Serife Badem, Adnan Karan, et al.Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|April 11, 2016
Tp-e Interval, Tp-e/QTc Ratio, and Fragmented QRS Are Correlated with the Severity of Liver CirrhosisMehmet Kadri Akboga, Mahmut Yuksel, Kevser Gulcihan Balci, et al.Hepato-Gastroenterology|July 24, 2012
Double balloon enteroscopy: a 3-year experience at a tertiary care centerIbrahim Koral Onal, Meral Akdogan, Mehmet Arhan, et al.Medicine|December 4, 2015
Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?Erkin Oztas, Ufuk Baris Kuzu, Neslihan Inci Zengin, et al.Journal of Viral Hepatitis|May 29, 2019
Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis BMargo J H van Campenhout, Vincent Rijckborst, Willem Pieter Brouwer, et al.The American Journal of Gastroenterology|May 13, 2010
A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis BVincent Rijckborst, Martijn J ter Borg, Yilmaz Cakaloglu, et al.The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|January 24, 2026
Fibrosis-4 Score and Postoperative Outcomes in Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatih Eren, Mehmet Refik Goktug, Derya Ari, et al.Hepatology (Baltimore, Md.)|August 5, 2010
Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levelsVincent Rijckborst, Bettina E Hansen, Yilmaz Cakaloglu, et al.European Journal of Gastroenterology & Hepatology|June 7, 2012
Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in respondersVincent Rijckborst, Peter Ferenci, Meral Akdogan, et al.Pageof 6